TUXUMDONLAR POLIKISTOZI SINDROMIGA BOG‘LIQ BEPUSHTLIKDA NUTRIENT-METABOLIK PROFILNING KLINIK-PATOGENETIK AHAMIYATI

Oyimjon Sadullayeva; Xolidajon Ikramova

Authors

Oyimjon Sadullayeva Xorazm viloyat Shovot tibbiyot birlashmasi. Akusherlik kompleksi. Akusher ginekolog Author
Xolidajon Ikramova Urganch Davlat tibbiyot instituti. PhD, v/b dotsent Author

Keywords:

TPKS, bepushtlik, nutrientlar, oksidativ stress, insulinrezistentlik

Abstract

Tuxumdonlar polikistoz sindromiga (TPKS) bog‘liq bepushtlikda nutrient-metabolik buzilishlar muhim o‘rin tutadi. Ushbu maqolada vitamin D, rux, selen yetishmovchiligi, insulinrezistentlik va oksidativ stressning reproduktiv funksiyaga ta’siri yoritilgan. Maqsad: Tuxumdonlar polikistoz sindromiga (TPKS) bog‘liq bepushtlikda nutrient-metabolik profilning klinik-patogenetik ahamiyatini o‘rganish. Material va metodlar: Tadqiqotga TPKS bilan bog‘liq bepushtligi bo‘lgan 70 nafar ayol va 20 nafar sog‘lom ayol kiritildi. Qonda vitamin D, magniy, rux, selen, insulin, AMH va HOMA-IR ko‘rsatkichlari aniqlandi. Oksidativ stress markerlari — MDA va TAC baholandi. Natijalar: Asosiy guruhda nutrient yetishmovchiligi, insulinrezistentlik va oksidativ stress ko‘rsatkichlari nazorat guruhiga nisbatan sezilarli yuqori aniqlandi (p<0,05). Nutrient tanqisligi ovulyator buzilishlar va giperandrogeniya bilan bog‘liq ekanligi aniqlandi. Xulosa: Nutrient-metabolik buzilishlar TPKSga bog‘liq bepushtlik patogenezida muhim ahamiyatga ega

Downloads

Download data is not yet available.

References

1. Икрамова Х.С., Матризаева Г.Д., Ражабова Г.О. Аёллардаги бепуштликда гиперандрогениянинг генетик аспектлари ва унинг ҳомиладорлик кечишига таъсири // Биология ва тиббиёт муаммолари.- Самарқанд, 2022. - № 6 (140), - Б. 132-135. (14.00.01. №19).

2. Икрамова Х.С., Матризаева Г.Д. Перспективы применения мелатонина при гормональном бесплодии // Новый день в медицине. – Бухара, 2021. - №6 (38/1). – Б. 257-263. (14.00.01. №22).

3. Azziz R., Carmina E., Dewailly D. et al. Positions statement: criteria for defining polycystic ovary syndrome. Fertility and Sterility. 2009;91(2):456–488.

4. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Human Reproduction. 2004;19(1):41–47.

5. Teede H.J., Misso M.L., Costello M.F. et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction. 2018;33(9):1602–1618.

6. Diamanti-Kandarakis E., Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited. Endocrine Reviews. 2012;33(6):981–1030.

7. Escobar-Morreale H.F. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nature Reviews Endocrinology. 2018;14(5):270–284.

8. Garg D., Tal R. The role of vitamin D in reproductive health: a review. BJOG. 2016;123(2):213–221.

9. Lerchbaum E., Obermayer-Pietsch B. Vitamin D and fertility: a systematic review. European Journal of Endocrinology. 2012;166(5):765–778.

10. Unfer V., Facchinetti F., Orrù B. et al. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocrine Connections. 2017;6(8):647–658.

11. Victor V.M., Rocha M., Bañuls C. et al. Oxidative stress, endothelial dysfunction and atherosclerosis. Current Pharmaceutical Design. 2009;15(26):2988–3002